St. John Paul II Krakow Specialist Hospital

John Paul II Specialist Hospital in Krakow has been operating since 1917 and has gradually changed its medical profile. It is one of the largest cardiopulmonary surgical centers in the country, which also conducts multicenter clinical research. The academic staff and cooperation with Jagiellonian University provide patients with access to the most innovative treatments with high recovery rates. The medical center complies with ISO 9001:2000 standards and is accredited by the Ministry of Health. The complex consists of 17 buildings with a maximum of 612 beds. Also, the organizational structure includes 19 inpatient departments, 27 outpatient counseling departments, and 40 specialized laboratories. The clinic serves almost 150,000 patients annually and performs 1,460 open-heart surgeries and 2,150 lung and chest surgeries. In addition, through many interventional procedures, doctors can improve existing treatment methods and gain invaluable experience in implementing new ideas. As early as 1957, the hospital performed the first open-heart surgeries and catheterization interventions in Poland. In the 2000s, heart surgeons traditionally took precedence in seamless implantation using 3F Therapeutics technology and percutaneous aortic valve replacement, TA-TAVI, and TAVI. Also, doctors mastered the closure of an aneurysm of the left ventricle of the heart by a minimally invasive method on a beating heart. This approach was a real breakthrough for the country. Furthermore, a minimally invasive mitral valve correction using the HARPOON system without cardiac arrest was a worldwide first at the John Paul II Clinic in Krakow. Numerous findings were also made by surgeons in pulmonology.  In particular, the first Polish implantation of an intrabronchial valve in a patient with pulmonary emphysema and the first-in-the-world pulmonary artery embolectomy using an innovative system.  In addition, doctors could remove large-diameter blood clots percutaneously. Today, doctors and surgeons do not stop at research and development of advanced treatments and carry out implantation of the world's smallest MicraTPS pacemakers and unique orbital atherectomy procedures.  Also, the medical center has significant achievements in treating patients with profound hypothermia and was recognized in anesthesiology with an award from the World Health Organization. In parallel with its cardiovascular dominance, the hospital operates a massive, highly integrated interdisciplinary unit for thoracic oncology and transplantology, which serves as a premier national pipeline for eradicating malignant chest diseases and terminal respiratory failures. Its thoracic surgery and advanced pulmonology teams specialize in complex, video-assisted thoracoscopic lung resections, intrabronchial valve implantations for severe emphysema, and the highly delicate, acute removal of massive thromboembolisms from the pulmonary arterial tree. This clinical architecture is strongly supported by an elite research ecosystem, including a dedicated molecular biology laboratory, making the hospital a leading European hub for both commercial and non-commercial clinical trials. Simultaneously, the hospital honors its deep infectious-disease roots by housing advanced provincial centers for pediatric neuroinfections, childhood hepatology, and adult viral hepatitis treatment. Through this masterful, century-long transition from a rustic isolation sanatorium to a hyper-modern, multi-disciplinary surgical empire, the hospital sets an unyielding international standard for biological restoration and academic medical triumph.